Convalescent plasma is the plasma collected from the recovered or convalesced people consisting of the antibodies against the infection causing microorganism.
The “Convalescent Plasma Therapy Industry Forecast” looks at past sales and reviews total world Convalescent Plasma Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Convalescent Plasma Therapy sales for 2023 through 2029. With Convalescent Plasma Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Convalescent Plasma Therapy industry.
This Insight Report provides a comprehensive analysis of the global Convalescent Plasma Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Convalescent Plasma Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Convalescent Plasma Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Convalescent Plasma Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Convalescent Plasma Therapy.
The global Convalescent Plasma Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Convalescent Plasma Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Convalescent Plasma Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Convalescent Plasma Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Convalescent Plasma Therapy players cover Bio Farma, Grifols, Hilton Pharma, Biotest, BPL, LFB, Octapharma, CSL Behring and Takeda Pharmaceutical Company Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Convalescent Plasma Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
IgM
IgG
IgA
Segmentation by application
Prophylaxis
Treatment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio Farma
Grifols
Hilton Pharma
Biotest
BPL
LFB
Octapharma
CSL Behring
Takeda Pharmaceutical Company Limited
Orthosera Kft
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Convalescent Plasma Therapy Market Size 2018-2029
2.1.2 Convalescent Plasma Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Convalescent Plasma Therapy Segment by Type
2.2.1 IgM
2.2.2 IgG
2.2.3 IgA
2.3 Convalescent Plasma Therapy Market Size by Type
2.3.1 Convalescent Plasma Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Convalescent Plasma Therapy Market Size Market Share by Type (2018-2023)
2.4 Convalescent Plasma Therapy Segment by Application
2.4.1 Prophylaxis
2.4.2 Treatment
2.5 Convalescent Plasma Therapy Market Size by Application
2.5.1 Convalescent Plasma Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Convalescent Plasma Therapy Market Size Market Share by Application (2018-2023)
3 Convalescent Plasma Therapy Market Size by Player
3.1 Convalescent Plasma Therapy Market Size Market Share by Players
3.1.1 Global Convalescent Plasma Therapy Revenue by Players (2018-2023)
3.1.2 Global Convalescent Plasma Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Convalescent Plasma Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Convalescent Plasma Therapy by Regions
4.1 Convalescent Plasma Therapy Market Size by Regions (2018-2023)
4.2 Americas Convalescent Plasma Therapy Market Size Growth (2018-2023)
4.3 APAC Convalescent Plasma Therapy Market Size Growth (2018-2023)
4.4 Europe Convalescent Plasma Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Convalescent Plasma Therapy Market Size Growth (2018-2023)
5 Americas
5.1 Americas Convalescent Plasma Therapy Market Size by Country (2018-2023)
5.2 Americas Convalescent Plasma Therapy Market Size by Type (2018-2023)
5.3 Americas Convalescent Plasma Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Convalescent Plasma Therapy Market Size by Region (2018-2023)
6.2 APAC Convalescent Plasma Therapy Market Size by Type (2018-2023)
6.3 APAC Convalescent Plasma Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Convalescent Plasma Therapy by Country (2018-2023)
7.2 Europe Convalescent Plasma Therapy Market Size by Type (2018-2023)
7.3 Europe Convalescent Plasma Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Convalescent Plasma Therapy by Region (2018-2023)
8.2 Middle East & Africa Convalescent Plasma Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Convalescent Plasma Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Convalescent Plasma Therapy Market Forecast
10.1 Global Convalescent Plasma Therapy Forecast by Regions (2024-2029)
10.1.1 Global Convalescent Plasma Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Convalescent Plasma Therapy Forecast
10.1.3 APAC Convalescent Plasma Therapy Forecast
10.1.4 Europe Convalescent Plasma Therapy Forecast
10.1.5 Middle East & Africa Convalescent Plasma Therapy Forecast
10.2 Americas Convalescent Plasma Therapy Forecast by Country (2024-2029)
10.2.1 United States Convalescent Plasma Therapy Market Forecast
10.2.2 Canada Convalescent Plasma Therapy Market Forecast
10.2.3 Mexico Convalescent Plasma Therapy Market Forecast
10.2.4 Brazil Convalescent Plasma Therapy Market Forecast
10.3 APAC Convalescent Plasma Therapy Forecast by Region (2024-2029)
10.3.1 China Convalescent Plasma Therapy Market Forecast
10.3.2 Japan Convalescent Plasma Therapy Market Forecast
10.3.3 Korea Convalescent Plasma Therapy Market Forecast
10.3.4 Southeast Asia Convalescent Plasma Therapy Market Forecast
10.3.5 India Convalescent Plasma Therapy Market Forecast
10.3.6 Australia Convalescent Plasma Therapy Market Forecast
10.4 Europe Convalescent Plasma Therapy Forecast by Country (2024-2029)
10.4.1 Germany Convalescent Plasma Therapy Market Forecast
10.4.2 France Convalescent Plasma Therapy Market Forecast
10.4.3 UK Convalescent Plasma Therapy Market Forecast
10.4.4 Italy Convalescent Plasma Therapy Market Forecast
10.4.5 Russia Convalescent Plasma Therapy Market Forecast
10.5 Middle East & Africa Convalescent Plasma Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Convalescent Plasma Therapy Market Forecast
10.5.2 South Africa Convalescent Plasma Therapy Market Forecast
10.5.3 Israel Convalescent Plasma Therapy Market Forecast
10.5.4 Turkey Convalescent Plasma Therapy Market Forecast
10.5.5 GCC Countries Convalescent Plasma Therapy Market Forecast
10.6 Global Convalescent Plasma Therapy Forecast by Type (2024-2029)
10.7 Global Convalescent Plasma Therapy Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Bio Farma
11.1.1 Bio Farma Company Information
11.1.2 Bio Farma Convalescent Plasma Therapy Product Offered
11.1.3 Bio Farma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bio Farma Main Business Overview
11.1.5 Bio Farma Latest Developments
11.2 Grifols
11.2.1 Grifols Company Information
11.2.2 Grifols Convalescent Plasma Therapy Product Offered
11.2.3 Grifols Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Grifols Main Business Overview
11.2.5 Grifols Latest Developments
11.3 Hilton Pharma
11.3.1 Hilton Pharma Company Information
11.3.2 Hilton Pharma Convalescent Plasma Therapy Product Offered
11.3.3 Hilton Pharma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Hilton Pharma Main Business Overview
11.3.5 Hilton Pharma Latest Developments
11.4 Biotest
11.4.1 Biotest Company Information
11.4.2 Biotest Convalescent Plasma Therapy Product Offered
11.4.3 Biotest Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Biotest Main Business Overview
11.4.5 Biotest Latest Developments
11.5 BPL
11.5.1 BPL Company Information
11.5.2 BPL Convalescent Plasma Therapy Product Offered
11.5.3 BPL Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 BPL Main Business Overview
11.5.5 BPL Latest Developments
11.6 LFB
11.6.1 LFB Company Information
11.6.2 LFB Convalescent Plasma Therapy Product Offered
11.6.3 LFB Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 LFB Main Business Overview
11.6.5 LFB Latest Developments
11.7 Octapharma
11.7.1 Octapharma Company Information
11.7.2 Octapharma Convalescent Plasma Therapy Product Offered
11.7.3 Octapharma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Octapharma Main Business Overview
11.7.5 Octapharma Latest Developments
11.8 CSL Behring
11.8.1 CSL Behring Company Information
11.8.2 CSL Behring Convalescent Plasma Therapy Product Offered
11.8.3 CSL Behring Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 CSL Behring Main Business Overview
11.8.5 CSL Behring Latest Developments
11.9 Takeda Pharmaceutical Company Limited
11.9.1 Takeda Pharmaceutical Company Limited Company Information
11.9.2 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product Offered
11.9.3 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Takeda Pharmaceutical Company Limited Main Business Overview
11.9.5 Takeda Pharmaceutical Company Limited Latest Developments
11.10 Orthosera Kft
11.10.1 Orthosera Kft Company Information
11.10.2 Orthosera Kft Convalescent Plasma Therapy Product Offered
11.10.3 Orthosera Kft Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Orthosera Kft Main Business Overview
11.10.5 Orthosera Kft Latest Developments
12 Research Findings and Conclusion
*If Applicable.